Spain – Various medicinal products – Suministro de productos farmacéuticos (Risankizumab, Lorlatinib, Dupilumab, Tucatin
Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil awarded €106K to UCB PHARMA,S.A for Construction & Public Works in October 2024 — one of 112 awards this buyer has made, below its typical award size.
Winning supplier
UCB PHARMA,S.AContract description
Spain – Various medicinal products – Suministro de productos farmacéuticos (Risankizumab, Lorlatinib, Dupilumab, Tucatinib y Bimekizumab), para el ComplejoHospitalario Universitario Insular-Materno Infantil de Gran Canaria.
Related awards · Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil
112 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-482711-2025GETINGE GROUP SPAIN, S.L.U.€631K23 Jul 2025 Construction
- ocds-ted-445553-2024Roche Farma, S.A.€615K24 Jul 2024 Construction
- ocds-ted-404842-2026Roche Farma, S.A.€570K12 Jun 2026 Construction
Other wins · UCB PHARMA,S.A
36 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil and UCB PHARMA,S.A — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back